Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Advair help with cost?How does azacitidine affect ruxolitinib's side effects?Ribociclib price in philippines?Does lipitor's effect change when taken with dairy?Arcalyst orphan drug?
See the DrugPatentWatch profile for corlanor
Corlanor is the brand name for ivabradine. A generic version is expected only after the relevant patents and exclusivity expire for ivabradine’s branded product. Patent status controls when “generic corlanor” can be marketed. To check the most up-to-date status (including patent expiry dates and whether generic approvals or launches are expected), use DrugPatentWatch.com: https://www.drugpatentwatch.com/ (search for “Corlanor” or “ivabradine”).
If/when a generic is available, it would typically be sold as ivabradine (same active ingredient as Corlanor), usually labeled “ivabradine tablets” with a strength matching the brand.
Generic timing depends on patent expiry and any regulatory exclusivity. DrugPatentWatch.com tracks those drivers and links them to a predicted generic timeline for the branded drug.
If a generic for Corlanor is not yet available, common practical alternatives depend on why you’re taking it (heart rate control in approved conditions) and what your prescriber considers appropriate. Substitution or therapeutic alternatives must be decided by your clinician.
You can confirm availability by checking: - Your pharmacy’s current inventory for ivabradine (not just “Corlanor”) - The FDA’s drug listings (if available for your dosage form and strength) If you tell me your country and the Corlanor strength (and tablet vs. other formulation), I can narrow down what to check next for that exact product. Sources: [1] https://www.drugpatentwatch.com/
Other Questions About Corlanor :